2022_Sep_ConnectinPharma_Easyfairs_Geneva

About

Christopher Hirst is Head of RPH Pharmaceuticals AB, a subsidiary of Stockholm-headquartered CDMO Recipharm AB. Mr Hirst has held business development and commercial roles at Recipharm, with a focus on generic and value-added medicines.

Top